Treatment of colorectal cancer in the elderly: A review of the literature

被引:38
作者
Golfinopoulos, V [1 ]
Pentheroudakis, G [1 ]
Pavlidis, N [1 ]
机构
[1] Univ Hosp Ioannina, Dept Med Oncol, Sch Med, GR-45110 Ioannina, Greece
关键词
colorectal cancer; elderly; chemotherapy; surgery;
D O I
10.1016/j.ctrv.2005.10.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although major progress has been achieved in the treatment of colorectal cancer, there are stilt several questions open for discussion concerning the management of elderly colorectal cancer patients. We conducted a review of the available literature concerning the use of adjuvant chemotherapy, palliative chemotherapy and surgery in elderly patients with colorectal cancer, using data from meta-analyses, non-systematic reviews and individual trials. All report similar survival benefits with adjuvant and palliative chemotherapy in elderly patients in comparison with younger age groups. Data on treatment-related side effects did not reveal a different toxicity profile for elderly patients. Efficacy and safety data were similar but more difficult to interpret concerning surgery, so this review is inconclusive about the proper use of this treatment modality in the elderly population. It is demonstrated that there is significant gain from chemotherapy in the adjuvant and palliative management of colorectal cancer patients irrespective of age. We, therefore, conclude that at[ patients should receive the most intensive treatment thought to be effective and safe, according to their biological age and comorbidities. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 28 条
  • [1] Au Heather-Jane, 2003, Clin Colorectal Cancer, V3, P165, DOI 10.3816/CCC.2003.n.022
  • [2] Brower M, 1993, P AN M AM SOC CLIN, V12, P195
  • [3] First-line oral capecitabine therapy in metastatic colorectal cancer:: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
    Cassidy, J
    Twelves, C
    Van Cutsem, E
    Hoff, P
    Bajetta, E
    Boyer, M
    Bugat, R
    Burger, U
    Garin, A
    Graeven, U
    McKendrick, J
    Maroun, J
    Marshall, J
    Osterwalder, B
    Pérez-Manga, G
    Rosso, R
    Rougier, P
    Schilsky, RL
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (04) : 566 - 575
  • [4] Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy
    Chau, I
    Norman, AR
    Cunningham, D
    Waters, JS
    Topham, C
    Middleton, G
    Hill, M
    Ross, PJ
    Katopodis, R
    Stewart, G
    Oates, JR
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (08) : 1453 - 1458
  • [5] Chiappa A, 2001, HEPATO-GASTROENTEROL, V48, P440
  • [6] Colorectal Canc Collaborative Grp, 2000, BMJ-BRIT MED J, V321, P531
  • [7] Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma - Final results of the southern Italy cooperative oncology group trial 0108
    Comella, P
    Natale, D
    Farris, A
    Gambardella, A
    Maiorino, L
    Massidda, B
    Casaretti, R
    Tafuto, S
    Lorusso, V
    Leo, S
    Cannone, M
    [J]. CANCER, 2005, 104 (02) : 282 - 289
  • [8] Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
    Cunningham, D
    Humblet, Y
    Siena, S
    Khayat, D
    Bleiberg, H
    Santoro, A
    Bets, D
    Mueser, M
    Harstrick, A
    Verslype, C
    Chau, I
    Van Cutsem, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) : 337 - 345
  • [9] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
    de Gramont, A
    Figer, A
    Seymour, M
    Homerin, M
    Hmissi, A
    Cassidy, J
    Boni, C
    Cortes-Funes, H
    Cervantes, A
    Freyer, G
    Papamichael, D
    Le Bail, N
    Louvet, C
    Hendler, D
    de Braud, F
    Wilson, C
    Morvan, F
    Bonetti, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 2938 - 2947
  • [10] Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study
    deGramont, A
    Basset, JF
    Milan, C
    Rougier, P
    Bouche, O
    Etienne, PL
    Morvan, F
    Louvet, C
    Guillot, C
    Francois, E
    Bedenne, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 808 - 815